Insider Cluster (4 insiders) ·Filed Feb 27, 2026

UTHR

UNITED THERAPEUTICS Corp
NEUTRAL
Impact 4/10
Horizondays Processed7mo ago
Insider cluster: 2 insiders, $127K total
Actionable Insight • Neutral

No meaningful insider selling pressure detected. The CEO's significant option exercises may signal confidence in holding, not exiting. Monitor for follow-on open-market selling or changes in sentiment ahead of earnings.

DirectionNeutral
Confidencehigh
Horizondays
Final — all horizons settled through T+60d
UTHR ▲ +15.39% at T+60d
NEUTRAL call ✓ call won +15.39% · α vs SPY +6.00% · entry $501.29 → $578.43
Entry anchored
Feb 26, 03:59 PM ET
via exchange tick
T+1d
+1.90%
call +1.90% · α +1.85%
$510.82
settled 7mo ago
T+5d
-5.14%
call -5.14% · α -3.16%
$475.52
settled 7mo ago
T+20d
+4.29%
call +4.29% · α +11.84%
$522.78
settled 6mo ago
T+60d
+15.39%
call +15.39% · α +6.00%
$578.43
settled 4mo ago

Price Chart

Loading chart...

Executive Summary

A recent insider trading cluster at United Therapeutics shows CEO Martine Rothblatt exercising options for nearly $2.8M in shares, while two other insiders conducted small open-market sales totaling $127K. The majority of activity consists of derivative exercises, not open-market selling.

Key Financial Metrics

Direction
mixed
Total Value
$127.4K
Insiders
4

Key Facts

  • CEO Martine Rothblatt exercised derivatives for 19,000 shares valued at $2,774,570 across two transactions on March 2 and 3, 2026.
  • Two open-market sales occurred: Malcolm Jan sold $25,460 worth of shares and Judy Olian sold $101,910 worth.
  • Total open-market selling in the cluster: $127,370 — consistent with recent 30-day insider activity.
  • Derivative exercises (M-coded transactions) are non-cash events and do not represent shares sold into the market.
  • Total insider open-market selling represents only 0.0006% of $21.5B market cap — immaterial in scale.

Financial Impact

$127,370 in open-market sales and $2.77M in derivative exercises (non-cash)

insider ownershippotential dilution

Risk Factors

  • Perception risk: Large derivative exercise by CEO could be misinterpreted as selling, though shares were not sold.
  • Minor open-market dispositions could signal portfolio rebalancing, but not alarmingly so.

Market Snapshot

Exchange
Nasdaq

Investment Themes

Biotech & Drug Discovery

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CONTEXT: Insider Cluster Data (5 trades, 7d window)cluster-UTHR-1772746519231
91 reports for UTHR
Performance horizon
80% Hit rate 4 of 5 directional calls best @ T+60▲ +5.53%Feb 25, 2026
Filters
Rows
Reports for UTHR — sortable, filterable
TypeNow
Sep 15, 2026
17d ago
Insider Cluster
NEUTRAL ★ 2/10
$500.35 $497.31▼ −0.61%▼ −2.72%$573.51 (+14.62%)
Sep 11, 2026
21d ago
Insider Cluster
NEUTRAL ★ 3/10
$497.11 $494.63▼ −0.50%▼ −0.28%$573.51 (+15.37%)
Sep 10, 2026
22d ago
Insider Cluster
MIXED ★ 4/10
$503.86 $497.27▼ −1.31%▼ −0.81%$573.51 (+13.82%)
Sep 9, 2026
23d ago
Insider Cluster
NEUTRAL ★ 3/10
$506.82 $498.48▼ −1.65%▼ −0.99%$573.51 (+13.16%)
Sep 4, 2026
28d ago
Insider Cluster
NEUTRAL ★ 2/10
$487.61 $502.70▲ +3.09%▲ +4.30%$573.51 (+17.62%)
Sep 3, 2026
29d ago
Insider Cluster
NEUTRAL ★ 2/10
$488.16 $497.11▲ +1.83%▲ +2.98%$573.51 (+17.48%)
Aug 28, 2026
5w ago
Insider Cluster
NEUTRAL ★ 2/10
$515.46 $487.61▼ −5.40%▼ −5.51%$573.51 (+11.26%)
Aug 27, 2026
5w ago
Insider Cluster
NEUTRAL ★ 2/10
$527.91 $492.02▼ −6.80%▼ −6.03%$573.51 (+8.64%)
Aug 26, 2026
5w ago
Insider Cluster
NEUTRAL ★ 3/10
$516.68 $492.02▼ −4.77%▼ −4.65%$573.51 (+11.00%)
Aug 25, 2026
5w ago
Insider Cluster
NEUTRAL ★ 2/10
$516.68 $492.02▼ −4.77%▼ −4.65%$573.51 (+11.00%)
Showing 10 of 91

US Market Status

Market Open — Closes in 6h 26m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access
Report published Mar 5, 2026